Cargando…

Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma

Neuroblastoma (NB) is a pediatric tumor of the sympathetic nervous system, which is often associated with elevated catecholamines. More than half of patients with metastatic NB relapse and survival is extremely poor with current therapies. In a high-throughput screen of FDA-approved drugs we identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolter, Jennifer K, Wolter, Nikolaus E, Blanch, Alvaro, Partridge, Teresa, Cheng, Lynn, Morgenstern, Daniel A., Podkowa, Monika, Kaplan, David R., Irwin, Meredith S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960198/ https://www.ncbi.nlm.nih.gov/pubmed/24389287

Ejemplares similares

Spy'ing on differentiation in neuroblastoma
por: Podkowa, Monika, et al.
Publicado: (2014)

The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer
por: Montoya, Alexa, et al.
Publicado: (2019)

Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021)

Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy
por: Ramsell, Stuart, et al.
Publicado: (2022)

The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study
por: Porcelli, Letizia, et al.
Publicado: (2020)

Beta-adrenergic receptor antagonists and chronic heart failure in children
por: Filippo, Sylvie Di
Publicado: (2007)

Propranolol, a β-adrenergic antagonist, attenuates the decrease in trabecular bone mass in high calorie diet fed growing mice
por: Baek, Kyunghwa, et al.
Publicado: (2014)

Beta 2 Adrenergic Receptor Antagonist Propranolol and Opioidergic Receptor Antagonist Naltrexone Produce Synergistic Effects on Breast Cancer Growth Prevention by Acting on Cancer Cells and Immune Environment in a Preclinical Model of Breast Cancer
por: Murugan, Sengottuvelan, et al.
Publicado: (2021)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance between Apoptosis and Autophagy
por: Cammalleri, Maurizio, et al.
Publicado: (2017)

Blockade of β-Adrenergic Receptors by Propranolol Disrupts Reconsolidation of Drug Memory and Attenuates Heroin Seeking
por: Chen, Liangpei, et al.
Publicado: (2021)

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup
por: Bouchard, Josée, et al.
Publicado: (2021)

Bradycardia From a Non-selective Beta-Adrenergic Antagonist, Timolol, Applied Ophthalmologically for Glaucoma
por: May, Gedaliah, et al.
Publicado: (2022)

β2-adrenergic receptor expression and the effects of norepinephrine and propranolol on various head and neck cancer subtypes
por: Kwon, Soon Young, et al.
Publicado: (2021)

Beta 2 Adrenergic Receptor Selective Antagonist Enhances Mechanically Stimulated Bone Anabolism in Aged Mice
por: E. Worton, Leah, et al.
Publicado: (2022)

Eukaryotic Translation Elongation Factor 1-Alpha 1 Inhibits p53 and p73 Dependent Apoptosis and Chemotherapy Sensitivity
por: Blanch, Alvaro, et al.
Publicado: (2013)

Propranolol exhibits activity against hemangiomas independent of beta blockade
por: Sasaki, Maiko, et al.
Publicado: (2019)

Change in mRNA Expression after Atenolol, a Beta-adrenergic Receptor Antagonist and Association with Pharmacological Response
por: Kohli, Utkarsh, et al.
Publicado: (2009)

Effects of Propranolol, a β-noradrenergic Antagonist, on Memory Consolidation and Reconsolidation in Mice
por: Villain, Hélène, et al.
Publicado: (2016)

The β-adrenergic receptor blocker and anti-inflammatory drug propranolol mitigates brain cytokine expression in a long-term model of Gulf War Illness
por: Michalovicz, Lindsay T., et al.
Publicado: (2021)

Beta-Adrenergic Blockade in Critical Illness
por: Bruning, Rebecca, et al.
Publicado: (2021)

Optical control of the β(2)-adrenergic receptor with opto-prop-2: A cis-active azobenzene analog of propranolol
por: Bosma, Reggie, et al.
Publicado: (2022)

Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma
por: Zimmerman, Mark W., et al.
Publicado: (2021)

Dinutuximab beta for neuroblastoma
Publicado: (2020)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
por: Komaki, Alireza, et al.
Publicado: (2014)

Beta-Adrenergic gene therapy for cardiovascular disease
por: Eckhart, Andrea D, et al.
Publicado: (2000)

Beta adrenergic blockade reduces utilitarian judgement
por: Sylvia, Terbeck, et al.
Publicado: (2013)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

The Clinical Pharmacology of Beta Adrenergic Blocking Drugs
por: McDevitt, D. G., et al.
Publicado: (1976)

The Role of Beta-Adrenergic Receptors in Depression and Resilience
por: Zhang, Hongxing, et al.
Publicado: (2022)

Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol
por: Johnson, Alexander K., et al.
Publicado: (2022)

QSPR analysis of some agonists and antagonists of α-adrenergic receptors
por: Kawczak, Piotr, et al.
Publicado: (2014)

Beta-Blocker Propranolol Modulates Decision Urgency During Sequential Information Gathering
por: Hauser, Tobias U., et al.
Publicado: (2018)

Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
por: Seebauer, Caroline T., et al.
Publicado: (2022)

Inhibition of signaling downstream of beta‐2 adrenoceptor by propranolol in prostate cancer cells
por: Alaskar, Aljoharah, et al.
Publicado: (2022)

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)

The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms
por: quốc Lu’o’ng, Khanh vinh, et al.
Publicado: (2012)

Drug Repositioning of the α(1)-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?
por: Florent, Romane, et al.
Publicado: (2020)

Morphology of astroglial cells is controlled by beta-adrenergic receptors
Publicado: (1987)

Beta-Adrenergic Modulation of Tremor and Corticomuscular Coherence in Humans
por: Baker, Mark R., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tsqhmiudfejlrndeb0rsga7765